According to researchers, targeting multiple angiogenesis pathways simultaneously could help overcome the resistance to anti-angiogenic treatment developed by glioblastoma brain cancer.
Researchers have developed a new method for creating custom tailored, two stage therapies for glioblastoma brain cancer.
Depriving glioblastoma brain cancer cells of cholesterol caused tumor regression and prolonged survival in mouse models of the disease, a new study reports.
Researchers have identified a pathway by which glioblastoma cancer cells aggressively spread and grow in the brain.
Researchers have developed a new drug that could help prolong the lives of people with glioblastoma brain cancer.
Researchers have identified an enzyme associated with aggressive gliomas.
Chemotherapy given directly to the brain in combination with immunotherapy may increase survival time for those with glioblastoma brain cancer a new study reports.
Glioblastmoa brain cancer patients who received an experimental vaccines in combination with chemotherapy showed improved suitability and tolerated the treatment well, a new study reports.
Researchers discover a mechanism that may underpin the progression of glioblastoma brain cancer development.
A new Baylor study reveals the CD44s molecule gives glioblastoma brain cancer cells a survival advantage. Removing CD44s from cancer cells and treating with erlotinib helped to promote the death of cancer cells than by just treating the cancer with erlotinib alone, researchers said.